Improvements seen in Parkinson's patients given NuPlasma young blood plasma
NeurologyLive - 25-Apr-201950% improvement in complications of therapy, 19.2% in motor examinations and more
Join the club for FREE to access the whole archive and other member benefits.
Associate editorial director at NeurologyLive
Matt Hoffman, Editor, NeurologyLive, has covered medical news for MJH Associates, NeurologyLive’s parent company, since 2017, and previously wrote for its sister publication, MD Mag. He has written for Science World Report, Headlines and Global News, The Philadelphia Inquirer, and NJ Advance Media. He attended Rowan University, where he studied journalism and web editing. He enjoys traveling, playing with his dog, and charcuterie plates.
Visit website: https://www.neurologylive.com/authors/matt-hoffman
See also
News source for breaking drug approvals, pipeline trials and emerging trends in neurology.
Details last updated 06-Feb-2020
50% improvement in complications of therapy, 19.2% in motor examinations and more